Truqap 160 mg

Truqap 160 mg is a tablet containing capivasertib, used for targeted therapy in cancer treatment. This medication is designed to inhibit specific proteins involved in cell growth.

Truqap 160 mg tablets are generally used in the treatment of certain types of cancer. Capivasertib, the active ingredient, is a kinase inhibitor that targets proteins involved in cell proliferation. This medication is often considered for patients who have specific genetic markers that make them suitable candidates for this type of therapy.

Common effects of Truqap 160 mg may include fatigue, nausea, and diarrhea. Some individuals might experience changes in appetite or skin reactions. It's important to monitor any unusual symptoms and consult a healthcare provider if they persist or worsen.

Truqap 160 mg should be handled with care, following the guidance of a healthcare professional. It is essential to store the medication properly and adhere to the prescribed regimen. Patients should be aware of potential side effects and report any severe or persistent issues to their doctor.

Truqap 160 mg may interact with other medications, including those that affect liver enzymes. It's crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods might also influence the effectiveness of this medication.